MedTrace Logo

Dexmedetomidine as an Adjuvant During Dural Puncture Epidural

NCT07506044 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-04-01

No results posted yet for this study

Summary

The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.

Conditions

  • Total Dose of Bupivacaine Administered During Labor

Interventions

DEVICE

Epidural Catheter with bupivacaine

epidural injection of plain Bup

DEVICE

Epidural with dural puncture

the dura is punctured by a 26-G spinal needle using the needle-through-needle technique, and is withdrawn after confirmation of free-flowing cerebrospinal fluid,

DRUG

Dexmedetomidine 0.4 added

Dexmedetomidine 0.4 added

DRUG

Dexmedetomidine 0.6 added

Dexmedetomidine 0.6 added

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2026-08-01
Completion
2026-08-30

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07506044 on ClinicalTrials.gov